https://sms.carm.es/ricsmur/handle/123456789/17864 Sat, 04 Apr 2026 02:47:11 GMT 2026-04-04T02:47:11Z https://sms.carm.es/ricsmur/handle/123456789/25638 Acceso a vacunación no financiada y factores socioeconómicos asociados en una cohorte de lactantes de un área sanitaria de la Región de Murcia Molina-Salas, Yolanda; Romera-Guirado, Francisco-José; Sánchez-Marin, María-del-Carmen; Navarro-Guerrero, Rosario; Romera-Guirado, María-Jesús; Pérez-Martin, Jaime-Jesús Tue, 19 Aug 2025 00:00:00 GMT https://sms.carm.es/ricsmur/handle/123456789/25638 2025-08-19T00:00:00Z https://sms.carm.es/ricsmur/handle/123456789/25524 Association of depression in multiple sclerosis with fatigue, sleep disturbances, disability, and health-related quality of life: Outcomes of a cross-sectional study Aparicio-Castro, Eladio; Candeliere-Merlicco, Antonio; Santa, CM; Villaverde-González, Ramón Wed, 01 Jan 2025 00:00:00 GMT https://sms.carm.es/ricsmur/handle/123456789/25524 2025-01-01T00:00:00Z https://sms.carm.es/ricsmur/handle/123456789/25430 Epidemiología del anciano en un servicio de urgencias hospitalarias de España. Estudio de 171.343 casos Merino-Gálvez, Esteban; Merino-Coy, Gabriela; Gómez-Hervás, Javier Thu, 10 Jul 2025 00:00:00 GMT https://sms.carm.es/ricsmur/handle/123456789/25430 2025-07-10T00:00:00Z https://sms.carm.es/ricsmur/handle/123456789/25451 Analysis of lipoprotein (a) determination in a selection of Spanish Clinical Laboratories. Batary study Arrobas-Velilla, Teresa; Martin-Pérez, Salomon; Fernández-Prendes, Carla; Castro-Castro, María-Jose; Camos-Anguila, Silvia; Leon-Justel, Antonio; Calmarza, Pilar; González-Martin, Irene; Puzo-Foncillas, Jose; Amigó-Grau, Núria; Candas-Estébanez, Baatriz; Ceacero-Marín, David; Martín-Palencia, María; Romero-Román, Carlos; Contreras-Sanfeliciano, Teresa; Fernández-Suarez, Antonio; Flores-Pardo, Emilio; Fernández-Fernández, Alejandra; Gómez-Cobo, Cristina; Ruiz-García, Lidya-Esther; Duque-Alcorta, Marta; Zabalza-Ollo, Beatriz; Riaño-Ruiz, Marta-M; Cuesta-Rodríguez, María-Jesús; Tapia-Artiles, Carlos; Rodríguez-Sánchez, Isabel; de-Medio, Enrique-Prada; Nieves-Fernández-Fatou, Blanca-M; Badía-Carnicero, María-Dolores; Fernández-Vizan, Elena; Boyero-García, Guillermo; Álvarez-Sastre, María-del-Pilar; García-Ruano, Ana-Belén; Bobillo-Lobato, Joaquín; Mar-Viloria-Peñas, María-del; Ortiz-García, Carmen; Blanco-Martín, Sonia; Cobos-Díaz, Andrés; Sahuquillo-Frías, Laura; Marcaida-Benito, Goizane; Cosmen-Sánchez, Ana; Belaustegui-Foronda, Ainhoa; Ne-Lengaran, Carmen-de; Gómez-Biedma-Gutiérrez, Simón; Zarauz-García, Jose; Cuadros-Muñoz, Juan; Calero-Ruiz, Mercedes; Sáez-Benito-Godino, Ana; Ramos-Álvarez, Mónica; Ruiz-Budría, José; Esteso-Perona, María; Rodríguez-Cantalejo, Fernando; Muñoz-Calero, María; Calbo-Caballos, Luis; Fernández-Grande, Esther; Fontán-Abad, Adrián; Lasierra-Monclus, Ana-Belén; Rico-Santana, Naira; del-Aguila, María-del-Mar; Barquero-Jiménez, Raquel; Redruello-Alonso, Alberto; García-Calcerrada, Isabel; de-Lózar-de-la-Viña, Alicia; Alonso-Castillejos, Nuria; Ramos-Mayordomo, Patricia; Lobo-Valentín, Rosa-María; Cojo-Espinilla, Alberto; Tadeo-Garisto, Virginia; Simó-Castelló, María; Aguado-Codina, Cristina; Peña-Cañaveras, Clara; Aguadero-Acera, Vicente; Tejedor-Mardomingo, Carmen; Morales-Portillo, Cristobal INTRODUCTION: Lipoprotein a is considered an independent factor of atherosclerotic cardiovascular disease with high prevalence, but the availability of real and updated data in Spain as well as determination protocols are limited. MAIN OBJECTIVE: Analyze the current state of the pre-analytical, analytical and post-analytical process of Lp (a) and assess the relationship with other variables. MATERIAL AND METHOD: Retrospective, observational, multicenter, anonymized study carried out in 2022 by survey of clinical laboratories. RESULTS: 21,926 determinations were obtained corresponding to 49 Laboratories. The values obtained were: Lp(a)>30mg/dl=46.87%, Lp(a)>50mg/dl 35.31%, Lp(a)>70mg/dl=26.8% Lp(a)>90mg/dl=19.3% with predominance of superiority in female gender in all established cut-off points. Almost 30% of primary care doctors do not have access to their application. 56.9% do not have a rejection criterion. 70.6% do not have protocols for its determination. There are two predominant analytical techniques, Immunophelometry (40%) and immunoturbidimetry (60%), 24% use nmon/L, 68% mg/dL and 8% report both. CONCLUSIONS: There is a low number of patients who have Lp(a) measured and of them the percentage of patients according to risk cut-off points are higher than those described. There is a lack of uniformity in pre-analytical, analytical and post-analytical processes in which it is necessary to work in a multidisciplinary manner to avoid future cardiovascular events. Sat, 01 Nov 2025 00:00:00 GMT https://sms.carm.es/ricsmur/handle/123456789/25451 2025-11-01T00:00:00Z